Medprin Regenerative Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of implantable medical devices in China and i...
Guangzhou Industry Investment-backed E-Jie Medical acquisition by Mypt Medical wins Shenzhen exchange approval
Medprin: Tang Ying has reduced her holdings by 0.9920%
Medprin released its performance for the first three quarters, with a net profit attributable to the parent company of 75.854 million yuan, an increase of 43.65%
Medprin: Plans to issue shares and pay cash to acquire assets and raise supporting funds of 134 million yuan
Medprin disclosed the progress of the equity transaction for acquiring Yijie Medical, with uncertainties still remaining
Medprin: Absorbable regenerated oxidized cellulose hemostatic granules enter clinical trial phase